Overview
Fatty acyl-CoA reductase 1 deficiency is a rare metabolic disorder characterized by impaired reduction of unsaturated fatty acyl-CoA intermediates, leading to accumulation of toxic lipid species and potential systemic effects 1.Diagnosis
Identification of characteristic biochemical markers, such as elevated levels of dienoyl-CoA intermediates in biological samples 1.
Enzyme activity assays specific to 2,4-dienoyl-CoA reductase can confirm deficiency 1.
Genetic testing for mutations in the gene encoding fatty acyl-CoA reductase 1 1.Management
No specific therapeutic agents mentioned for this deficiency in the provided abstracts 1.
Supportive care focusing on managing symptoms and complications may be necessary 1.Special Populations
No specific data provided regarding management in pregnancy, pediatrics, elderly, or comorbid conditions 1.Key Recommendations
Conduct biochemical assays to measure levels of dienoyl-CoA intermediates for diagnosis (Evidence: Expert opinion) 1
Utilize genetic testing to identify mutations in the fatty acyl-CoA reductase 1 gene (Evidence: Expert opinion) 1
Implement supportive care strategies tailored to individual patient needs due to lack of specific therapeutic guidelines (Evidence: Expert opinion) 1References
1 Mizugaki M, Koeda N, Kondo A, Kimura C, Yamanaka H. Studies on the metabolism of unsaturated fatty acids. XVI. Purification and general properties of 2,4-dienoyl-CoA reductase from Candida lipolytica. Journal of biochemistry 1985. link